Series reports of the 8th China Hospital Pharmaceutical Policy Forum IV: the role of pharmacists in the adjustment of medical insurance catalogue

Source: Feng Wanyu, director of Pharmacy Department of Peking University People's Hospital, China Association for the promotion of pharmaceutical innovation, made a theme report on "the role of pharmacists in the adjustment of medical insurance catalog" at the 8th hospital pharmacy Forum on July 25, 2017 She made an in-depth interpretation of the role pharmacists should and can play in the adjustment of the new version of the medical insurance catalogue and the adjustment of the future medical insurance policy Feng Wanyu, director of Pharmacy Department of Peking University People's Hospital Director Feng Wanyu discussed the positioning and inclusion of the medical insurance drug catalog, pointed out that the 2017 version of the medical insurance drug catalog and the 2009 version of the medical insurance drug catalog had changes in disease spectrum (coverage of treatment scope), patient population, aging degree, etc., so the new version of the catalog was given to the elderly, children, tumor patients, dialysis patients and orphans In the process of medical insurance drug negotiation, the legal consultant was hired to check the legitimacy, the expert group of pharmacoeconomics evaluation was set up, the accurate calculation of big data analysis and the calculation of the support ability of medical insurance fund were carried out In her opinion, pharmacists not only have the experience of pharmaceutical education in Colleges and universities (such as pharmaceutical basic courses, clinical pharmaceutical practice, therapeutic drug management, etc.), but also have the experience of individualized and common service practice accumulated in many years of pharmaceutical care for patients Pharmacists should be able to base on macro factors (population and economy, policy factors, etc.) and micro factors (industry norms, enterprises, etc.) Progress and other dynamic situations) to provide relevant suggestions for the adjustment of medical insurance catalog Moreover, because pharmacists participate in all aspects of drug circulation and use, the responsibility of pharmacists should be to do a good job in the quality control and drug risk supervision of Medicare drugs, to ensure that drugs play their due role in the whole life cycle and achieve the best effect She introduced the case of the role of Chinese pharmacists in the adjustment of Medicare drug catalogue Based on the results of clinical big data, considering the changes of disease spectrum, clinical needs, special patient groups and the bearing capacity of medical insurance fund, pharmacists recommend or eliminate the varieties and problems existing in the process of drug access in the catalogue, and expand the clinical needs (for example: some drugs are new varieties and specifications to meet the clinical needs), special disease / rare The substantial suggestions and opinions on drug adjustment are put forward in the aspects of drug inclusion, drug dosage form expansion (such as new targeted liposome), property transformation of Chinese and Western medicine, control of infusion hazards (transformation of limited use scope of some injection), disease spectrum change, etc At the same time, she suggested that in the future, pharmacists should strengthen the research on the effectiveness, safety, economy and accessibility of drugs, and make better use of the evaluation results of evidence-based medicine and pharmacoeconomics and market big data analysis to further improve the national medical insurance catalog and dynamically adjust the medical insurance catalog.